Elevai Labs plans a reverse stock split to boost its share price and stay on the Nasdaq.

Elevai Labs Inc., a California-based medical company, plans a 1-for-200 reverse stock split on November 27 to meet Nasdaq's $1.00 minimum share price requirement. This action will reduce the number of outstanding shares to about 3.07 million but maintain the total value of shareholders' equity. The move aims to keep Elevai on the Nasdaq Capital Market.

November 23, 2024
4 Articles